{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:24:28Z","timestamp":1790501068393,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004295","name":"Key Science and Technology Program of Shandong Province","doi-asserted-by":"publisher","award":["2009GG20002016"],"award-info":[{"award-number":["2009GG20002016"]}],"id":[{"id":"10.13039\/501100004295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbrc.2017.06.020","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T10:01:00Z","timestamp":1496916060000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice"],"prefix":"10.1016","volume":"490","author":[{"given":"Zaicun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huating","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.bbrc.2017.06.020_bib1","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.2174\/138161212802481237","article-title":"Atherosclerosis as an inflammatory disease","volume":"18","author":"Tuttolomondo","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bbrc.2017.06.020_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2017.06.020_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijcard.2015.03.055","article-title":"Macrophage phenotypic plasticity in atherosclerosis: the associated features and the peculiarities of the expression of inflammatory genes","volume":"184","author":"Chistiakov","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.bbrc.2017.06.020_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000079706","article-title":"Role of JAK\/STAT pathway in IL-6-induced activation of vascular smooth muscle cells","volume":"24","author":"Watanabe","year":"2004","journal-title":"Am. J. Nephrol."},{"issue":"11","key":"10.1016\/j.bbrc.2017.06.020_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0891-5849(01)00649-9","article-title":"Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein","volume":"31","author":"Maziere","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2017.06.020_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/ATVBAHA.108.173781","article-title":"Suppressors of cytokine signaling modulate JAK\/STAT-mediated cell responses during atherosclerosis","volume":"29","author":"Ortiz-Munoz","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2017.06.020_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00395-014-0458-1","article-title":"Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice","volume":"110","author":"Recio","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"5646","key":"10.1016\/j.bbrc.2017.06.020_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bbrc.2017.06.020_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/1060028013512790","article-title":"Tofacitinib: the First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis","volume":"47","author":"Vyas","year":"2013","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbrc.2017.06.020_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2011.12.156","article-title":"Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation","volume":"418","author":"Yoshida","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.06.020_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.01.053","article-title":"Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis","author":"Merola","year":"2017","journal-title":"J.\u00a0Am. Acad. Dermatol"},{"key":"10.1016\/j.bbrc.2017.06.020_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2017.66","article-title":"IBD: tofacitinib effective in ulcerative colitis","author":"Bradley","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5081","key":"10.1016\/j.bbrc.2017.06.020_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2017.06.020_bib14","first-page":"7","article-title":"Specificity of action of colony-stimulating factors in the differentiation of granulocytes and macrophages","volume":"118","author":"Nicola","year":"1986","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.bbrc.2017.06.020_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2016.12.164","article-title":"How do macrophages sense modified low-density lipoproteins?","volume":"230","author":"Chistiakov","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.bbrc.2017.06.020_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.108.182303","article-title":"Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis","volume":"29","author":"Brunham","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2017.06.020_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.atherosclerosis.2008.07.029","article-title":"IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK\/STAT signaling pathway-dependent manner","volume":"203","author":"Hao","year":"2009","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.bbrc.2017.06.020_bib18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5551\/jat.6569","article-title":"AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK\/STAT signaling pathway-dependent manner","volume":"18","author":"Mo","year":"2011","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"11","key":"10.1016\/j.bbrc.2017.06.020_bib19","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1253\/circj.CJ-14-0193","article-title":"Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice","volume":"78","author":"Mo","year":"2014","journal-title":"Circ. J."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17311324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17311324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T02:40:48Z","timestamp":1617331248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17311324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0006291X17311324"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.020","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}